Cytokinetics (CYTK) Retained Earnings (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Retained Earnings of -$3.7 billion for Q1 2026, down 28.98% year-over-year from -$5.2 billion in Q1 2025, and down 586250.79% quarter-over-quarter from $630000.0 in Q4 2025.
Cytokinetics (CYTK) Retained Earnings (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Retained Earnings for 17 consecutive years, with -$3.7 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 28.98% year-over-year to -$3.7 billion; the TTM figure through Mar 2026 stood at -$3.7 billion (down 28.98% YoY), while the FY2025 annual figure was $630000.0, up 100.02% from the prior year.
- Retained Earnings declined to -$3.7 billion in Q1 2026 per CYTK's latest filing, from $630000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $5.4 million in Q3 2024 and bottomed at -$3.7 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$1.6 billion across 5 years, with a median of -$1.6 billion in 2022.
- On a YoY basis, Retained Earnings climbed as much as 100.27% in 2024 and fell as far as 27017540.0% in 2024.
- Cytokinetics' Retained Earnings stood at -$1.6 billion in 2022, then surged by 100.0% to -$10000.0 in 2023, then slumped by 27017540.0% to -$2.7 billion in 2024, then jumped by 100.02% to $630000.0 in 2025, then sank by 586250.79% to -$3.7 billion in 2026.
- Business Quant data shows CYTK's Retained Earnings at -$3.7 billion in Q1 2026, $630000.0 in Q4 2025, and -$3.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | -3.90 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.90 Bn |
| Mar 31, 2026 | -3.69 Bn |
| Dec 31, 2025 | 630,000.00 |
| Sep 30, 2025 | -3.30 Bn |
| Jun 30, 2025 | -3.00 Bn |
| Mar 31, 2025 | -2.86 Bn |
| Dec 31, 2024 | -2.70 Bn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | -2.39 Bn |
| Mar 31, 2024 | -539,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | -1.98 Bn |
| Jun 30, 2023 | -1.85 Bn |
| Mar 31, 2023 | -1.65 Mn |
| Dec 31, 2022 | -1.59 Bn |
| Sep 30, 2022 | -1.45 Bn |
| Jun 30, 2022 | -1.31 Bn |
| Mar 31, 2022 | -1.29 Bn |
| Dec 31, 2021 | -869,000.00 |
| Sep 30, 2021 | -65,000.00 |